申请人:——
公开号:US20020077486A1
公开(公告)日:2002-06-20
Novel compounds of formulae (I) to (VIII), which more particularly include sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives which are effective platelet ADP receptor inhibitors. These derivatives may be used in various pharmaceutical compositions, and are particularly effective for the prevention and/or treatment of cardiovascular diseases, particularly those diseases related to thrombosis. The invention also relates to a method for preventing or treating thrombosis in a mammal comprising the step of administering a therapeutically effective amount of a compound of formulae (I) to (VIII), or a pharmaceutically acceptable salt thereof.
化合物的新颖结构式(I)至(VIII),其中更特别包括磺酰脲衍生物、磺酰硫脲衍生物、磺酰胍衍生物、磺酰氰胍衍生物、硫代酰基磺酰胺衍生物和酰基磺酰胺衍生物,这些衍生物是有效的血小板ADP受体抑制剂。这些衍生物可用于各种药物组合中,特别适用于预防和/或治疗心血管疾病,特别是与血栓形成相关的疾病。该发明还涉及一种用于预防或治疗哺乳动物体内血栓形成的方法,包括给予化合物的治疗有效量的步骤,该化合物为结构式(I)至(VIII)中的一种,或其药学上可接受的盐。